Aldeyra Therapeutics
Aldeyra faces FDA rejection risk for dry eye drug due to review issues
Anika Sharma
Aldeyra Therapeutics confronts a daunting situation as regulatory concerns cast doubt on the future of its dry eye disease medication, ...
FDA rejects Aldeyra’s eye cancer treatment, citing a lack of clinical data, shattering hopes
SG Tylor
Source – Aldeyra Therapeutics On June 21, 2023, Aldeyra disclosed that they have received a Complete Response Letter from the ...
